CA Healthcare Acquisition in an 8-K filing today included an alalyst presentation on its pending merger with LumiraDx, a diagnostics testing company. The combination reflects a value of $5 billion for Lumira’s existing equity.
LumiraDx has raised $700 million in equity capital including investments by Morningside Ventures, U.S. Boston Capital Corporation, The Bill & Melinda Gates Foundation, Petrichor Healthcare Capital Management and other strategic partners. The company had originally planned a traditional IPO before taking the SPAC route to market.
CA Healthcare raised $115 million in its IPO. The deal is expected to close in the third quarter. Read more.
